TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,824 Cr | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr | ₹1,976 Cr |
What is the latest Operating Profit of TORRENT PHARMACEUTICALS ?
Year | Operating Profit |
---|---|
Mar2024 | ₹2,824 Cr |
Mar2023 | ₹2,431 Cr |
Mar2022 | ₹2,480 Cr |
Mar2021 | ₹2,170 Cr |
Mar2020 | ₹1,976 Cr |
How is Operating Profit of TORRENT PHARMACEUTICALS Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹2,824 Cr | 16.15 | |
Mar2023 | ₹2,431 Cr | -1.97 | |
Mar2022 | ₹2,480 Cr | 14.27 | |
Mar2021 | ₹2,170 Cr | 9.81 | |
Mar2020 | ₹1,976 Cr | - |
Compare Operating Profit of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹110,051.1 Cr | 1.4% | -1.5% | 13.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,614.0 Cr | -2.5% | -4.7% | 11.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,533.0 Cr | -2.7% | -0.7% | 50.4% | Stock Analytics | |
CIPLA | ₹121,439.0 Cr | -1.2% | 0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,076.0 Cr | -2.3% | 8.2% | 11.1% | Stock Analytics | |
MANKIND PHARMA | ₹97,090.3 Cr | -1.1% | -8.1% | 6.5% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 1.4% |
-1.5% |
13.3% |
SENSEX | -1% |
-0.9% |
6.7% |
You may also like the below Video Courses